Short Interest in INVO Fertility, Inc (NASDAQ:IVF) Grows By 281.1%

INVO Fertility, Inc (NASDAQ:IVF) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 94,554 shares, an increase of 281.1% from the November 30th total of 24,811 shares. Based on an average trading volume of 982,155 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.0% of the shares of the company are sold short. Approximately 4.0% of the shares of the company are sold short. Based on an average trading volume of 982,155 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in INVO Fertility stock. Citadel Advisors LLC purchased a new position in INVO Fertility, Inc (NASDAQ:IVF) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned approximately 1.19% of INVO Fertility at the end of the most recent quarter. 12.02% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of INVO Fertility in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, INVO Fertility currently has a consensus rating of “Sell”.

INVO Fertility Stock Down 1.3%

Shares of INVO Fertility stock traded down $0.01 during trading hours on Thursday, reaching $0.87. 52,625 shares of the stock traded hands, compared to its average volume of 1,028,651. INVO Fertility has a one year low of $0.86 and a one year high of $299.52. The firm has a market capitalization of $2.09 million, a price-to-earnings ratio of 0.00 and a beta of 2.54. The company has a 50 day moving average price of $3.14 and a 200 day moving average price of $10.82.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.